news & events

Check out what we’ve been up to and where we can connect!


Evaluation of baricitinib versus dexamethasone for adults hospitalized with COVID-19 in the global ACTT-4 study

September 7, 2022
The global ACTT-4 study, supported by FHI Clinical, evaluated baricitinib vs dexamethasone for adults hospitalized with COVID-19. This trial is the fourth and final stage in a series of phase 3, randomized, double-blind, placebo-controlled trials to evaluate the clinical efficacy and safety of investigational therapeutic agents in hospitalized adults with laboratory-confirmed COVID-19.

Read more »

FHI Clinical announces the closing of its acquisition of the clinical trials business of South Africa-based Triclinium Clinical Development (TCD)

February 8, 2022
FHI Clinical Inc. announces today the official closing of its acquisition of the clinical trials business of Triclinium Clinical Development Proprietary Limited (TCD), a full-service, South Africa-based CRO. With the acquisition, FHI Clinical expands its share of the infectious disease (ID) clinical development market and becomes the dominant service provider in sub-Saharan Africa.

Read more »


SCOPE 2023

February 6-9, 2023
Attending SCOPE? Schedule a meeting with an FHI Clinical team member who will be attending.

Read more »

ASTMH 2022

October 30 – November 3, 2022
Attending the ASTMH Annual Meeting 2022? Stop by our booth to chat with members of our team will be available to talk about your ongoing and future projects.

Read more »
H3D Symposium

2022 H3D Symposium

October 25-28, 2022
Attending the 2022 H3D Symposium? Contact us to set aside time to talk about how our capabilities, local team and long-standing experience in sub-Saharan Africa can benefit your clinical trials in the region.

Read more »

World Vaccine Congress Europe 2022

October 11-14, 2022
Visit us in booth 79 at World Vaccine Congress Europe to learn what it means to be INSIDE AFRICA – experience the tastes, smells and sounds of sub-Saharan Africa and meet with our team members to discuss how your clinical trials would benefit from our experience on the African continent.

Read more »